Cost-effectiveness analysis of second-line chemotherapy strategies for patients with advanced non-squamous non-small cell lung cancer

Subjects

Subjects :

Oncology
medicine.medical_specialty
business.industry
Pharmaceutical Science
Cost-effectiveness analysis
medicine.disease
Second line chemotherapy
Gemcitabine
Pemetrexed
Docetaxel
Non squamous
Internal medicine
medicine
Non small cell
business
Lung cancer
medicine.drug

Details

ISSN :

10031057

Volume :

29

Database :

OpenAIRE

Journal :

Journal of Chinese Pharmaceutical Sciences

Accession number :

edsair.doi...........801c6e045b8b041dc57f3f61b0712e3d

Full Text :

https://doi.org/10.5246/jcps.2020.08.051